SCHEMBL29587796

SCHEMBL29587796

O=CNCc1cccc(Cl)c1

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADH1B P00325 1/20 0.59
ADH1C P00326 1/20 0.59
ADH1A P07327 1/20 0.59
ADH7 P40394 1/20 0.59
CHRM2 P08172 2/20 0.58
HDAC1 Q13547 1/20 0.50
PNMT P11086 1/20 0.48
CYP3A4 P08684 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C19 P33261 1/20 0.47
LMNA P02545 1/20 0.46
CHRM1 P11229 1/20 0.46
CHRM3 P20309 1/20 0.46
TAAR1 Q96RJ0 2/20 0.46
ACHE P22303 4/20 0.44
IDO1 P14902 1/20 0.44
AGXT P21549 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3303150 1.00 ADH1B (0.59) ADH1BADH1CADH1AADH7CHRM2
SCHEMBL4344655 0.92 PNMT (0.65) ADH1BADH1CADH1AADH7CHRM2
SCHEMBL8750958 0.86 ADH1B (0.71) ADH1BADH1CADH1AADH7CHRM2
SCHEMBL2473716 0.83 TAAR1 (0.62) CHRM2HDAC1CYP3A4CYP1A2CYP2D6
SCHEMBL7066938 0.81 CHRM2 (0.74) CHRM2HDAC1PNMTCYP3A4CYP1A2
SCHEMBL3514620 0.81 CHRM2 (0.53) CHRM2HDAC1PNMTCYP3A4CYP1A2
SCHEMBL12614632 0.81 CHRM2 (0.53) CHRM2HDAC1PNMTCYP3A4CYP1A2
SCHEMBL350370 0.79 ADH1B (0.50) ADH1BADH1CADH1AADH7LMNA
SCHEMBL11673587 0.78 CHRM2 (0.89) CHRM2CYP3A4CYP1A2CYP2D6CYP2C19
SCHEMBL7774786 0.78 CHRM2 (0.81) CHRM2HDAC1PNMTCYP3A4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109863145-B Novel tetrahydroisoquinoline and tetrahydronaphthyridine compounds for the treatment and prevention of hepatitis b virus infection 豪夫迈·罗氏有限公司 2022-04-12 CN disclosed